In the first six months of 2023, approximately 6 million prescriptions were written for the class of drugs that include Wagovi and Ozempic. These medications assist in insulin production and signal the brain to reduce appetite. However, with the festive season upon us, some individuals using weight loss drugs are contemplating skipping their doses. To shed light on this matter, we turn to Dr. Lena Wynn, an esteemed expert in the field.
Dr. Wynn emphasizes the potential side effects associated with these drugs, such as nausea, vomiting, diarrhea, constipation, and stomach pain. Understandably, these symptoms may not align well with the enjoyment of Christmas, vacations, or other celebratory occasions. However, Dr. Wynn urges patients to view obesity as a chronic condition and weight loss drugs as similar to medications for high blood pressure, diabetes, or heart disease. Just as it's important not to stop those medications without consulting a doctor, the same holds true for semaglutide, including Wagovi and Ozempic. Seeking individualized advice from a healthcare professional is crucial in making informed decisions.
Dr. Wynn also addresses the potential risks associated with pausing and restarting weight loss drug treatment. Stating that these medications are typically administered on a weekly basis, missing a single dose does not eliminate its effects from the body. Timing the pause in treatment to reduce side effects requires guidance from a physician. It is vital to avoid potential negative health consequences while hoping for the desired benefits.
With the new year right around the corner, many individuals are setting resolutions and goals for themselves. It is anticipated that doctors will receive numerous inquiries about weight loss drugs during this time. Dr. Wynn highlights that more than 40% of Americans suffer from obesity, which not only has adverse health effects but also increases the risk of other conditions such as diabetes and heart disease. While these medications provide an additional tool in the fight against obesity, they should be used in conjunction with lifestyle changes, such as maintaining a healthy diet and regular exercise. Ultimately, the goal is improved overall health as we enter the new year.
As we bid farewell to 2022 and eagerly welcome 2023, it is important to prioritize our well-being. Weight loss drugs can be a helpful tool for some individuals, but their usage should be carefully monitored and adjusted in consultation with a healthcare professional. Let us embark on the new year with a commitment to better health and a deeper understanding of how to navigate our personal journeys to wellness.
